文献速递消化道肿瘤与早癌

果糖通过调控癌相关成纤维细胞与肿瘤细胞交互驱动结直肠癌进展

Fructose drives colorectal cancer progression by regulating crosstalk between cancer-associated fibroblasts and tumour cells.
PubMed 文献 · Gut · 2025-09-11

本研究探讨果糖介导的癌相关成纤维细胞(CAF)重编程在结直肠癌(CRC)进展中的调控作用与分子机制。果糖在CRC细胞和CAF中均通过GLUT5发挥作用,CAF的果糖代谢增强其增殖、迁移和活化,CRC细胞的果糖利用则释放核苷酸和氨基酸激活CAF并上调CXCL14,进而促进肿瘤细胞迁移和转移。CAF中GLUT5表达与更晚期肿瘤分期和更差预后相关。

要点

  • 果糖通过GLUT5在CRC细胞和CAF中发挥双重促癌作用
  • CAF果糖代谢增强其增殖、迁移和活化
  • CRC细胞果糖利用释放代谢物激活CAF并上调CXCL14促进转移

核心结论

  • 果糖通过调控肿瘤-基质交互促进CRC进展,靶向果糖代谢可能破坏驱动恶性肿瘤的肿瘤-基质串扰。

研究设计与样本

  • 检测果糖及果糖培养的肿瘤细胞对CAF生物学功能的影响。
  • 采用代谢组学和转录组学分析表征果糖调控的肿瘤细胞与CAF串扰网络。
  • 分析CAF中GLUT5表达水平与CRC患者临床病理特征及预后的关系。

主要发现

  • 果糖通过影响肿瘤细胞和CAF双重促进CRC进展。
  • GLUT5在CRC细胞和CAF中均有表达,其表达与更晚期肿瘤分期和更差预后相关。
  • CAF果糖代谢增强其增殖、迁移和活化。
  • CRC细胞果糖利用导致核苷酸和氨基酸释放,这些代谢物激活CAF并上调趋化因子CXCL14表达。
  • CXCL14上调进而促进肿瘤细胞迁移和转移。

临床怎么用

  • CAF中GLUT5表达水平可能作为CRC分期和预后的参考指标。
  • 靶向果糖代谢可能成为破坏肿瘤-基质串扰的治疗策略。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Fructose has been identified as a potential alternative energy source for cancer cells, facilitated by the fructose-specific transporter GLUT5. Elevated GLUT5 expression in cancer cells has been associated with increased tumour aggressiveness. However, the role of fructose in remodelling the tumour microenvironment, particularly in modulating cancer-associated fibroblast (CAF) behaviour, remains underexplored. OBJECTIVE: This study aimed to elucidate the regulatory effects and molecular mechanisms of fructose-mediated CAF reprogramming in colorectal cancer (CRC) progression. DESIGN: The effects of fructose and fructose-cultured tumour cells on biological function of CAFs were detected. Metabolomics and transcriptomic analyses were used to characterise the fructose-regulated crosstalk network of tumour cells and CAFs. Furthermore, the relationships between GLUT5 expression level in CAFs and clinicopathological features and prognosis of patients with CRC were analysed. RESULTS: We demonstrate that fructose plays a dual role in promoting CRC progression by influencing both tumour cells and CAFs. GLUT5 is expressed in both CRC cells and CAFs, with its expression correlating with more advanced tumour stages and poorer outcomes in patients. Fructose metabolism in CAFs enhances their proliferation, migration and activation, while fructose utilisation by CRC cells leads to the release of nucleotides and amino acids. These metabolites activate CAFs and upregulate the expression of the chemokine CXCL14. This, in turn, promotes tumour cell migration and metastasis. CONCLUSIONS: These findings reveal a novel mechanism by which fructose fosters tumour progression through the modulation of tumour-stroma interactions, and highlight the therapeutic potential of targeting fructose metabolism in CRC to disrupt the tumour-stroma crosstalk that drives malignancy.

来源:Gut,查看原文。版权归原作者所有。

引用

  1. Cui Y, Liu H, Zhang L, et al. Fructose drives colorectal cancer progression by regulating crosstalk between cancer-associated fibroblasts and tumour cells. Gut. 2025. PMID: 40935617. doi:10.1136/gutjnl-2025-335014

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。